Paediatric Liver, GI and Nutrition Centre and Mowatlabs.
Institute of Liver Studies.
J Pediatr Gastroenterol Nutr. 2021 Jul 1;73(1):93-98. doi: 10.1097/MPG.0000000000003116.
To assess the utility of prognostic scoring systems for adolescents with biliary atresia (BA) surviving with native liver, for predicting the subsequent requirement for liver transplantation (LT).
Single-centre retrospective analysis of 397 BA patients who received Kasai Portoenterostomy (KP) 1980-1996 and survived with the native liver at 16 years. Laboratory and clinical variables at 16 years (timepoint 16 years) were used to calculate (i) LT allocation scores; Model for End-Stage Liver Disease [MELD/MELD-sodium (Na)], and UK End-Stage Liver Disease (UKELD); (ii) Mayo Primary Sclerosing Cholangitis risk score (MayoPSC) and (iii) a modified Paediatric End-Stage Liver Disease (PELD) score. Scores were compared between patients requiring LT after 16 years of age (LT > 16 years), and those who survived with native liver, at the latest follow-up. Additional subgroup analysis for patients with data available at 12 years (timepoint 12 years).
MELD (area under the receiver operating characteristic [AUROC] 0.847) and UKELD (AUROC: 0.815) at 16 years of age predict the need for LT > 16 years. No advantage for MELD-Na over MELD was demonstrated. MELD >8.5 and UKELD >47 predicted LT > 16 years with 84% and 79% sensitivity and 73% and 73% specificity. PELD had a similar performance to MELD, but superiority to UKELD. MayoPSC revealed predictive accuracy for LT >16 years (AUROC 0.859), with a score of >0.87 predicting LT > 16 years with 85% sensitivity and 82% specificity. At timepoint 12 years, MELD and MayoPSC predicted LT >16 years. Change in MELD, PELD and MayoPSC between 12 and 16 years of age, was associated with LT >16 years.
Adult LT allocation scores may help monitor progress in adolescent BA, but the omission of relevant risk factors limits their utility for listing in this cohort. A BA-specific prognostic score would improve the management of adolescent BA.
评估用于评估先天性肝内胆汁淤积症(BA)存活患者的预后评分系统,以预测后续肝移植(LT)的需求。
对 1980 年至 1996 年接受 Kasai 门腔分流术(KP)的 397 例 BA 患者进行单中心回顾性分析,这些患者在 16 岁时存活并具有原生肝脏。使用 16 岁(时间点 16 岁)时的实验室和临床变量来计算(i)LT 分配评分;终末期肝病模型[MELD/MELD-钠(Na)]和英国终末期肝病评分(UKELD);(ii)Mayo 原发性硬化性胆管炎风险评分(MayoPSC)和(iii)改良小儿终末期肝病评分(PELD)。比较 16 岁后需要 LT 的患者(LT>16 岁)与最晚随访时存活的患者之间的评分。对于在 12 岁时具有数据的患者进行额外的亚组分析(时间点 12 岁)。
MELD(受试者工作特征曲线下面积[AUROC]0.847)和 UKELD(AUROC:0.815)在 16 岁时可预测 LT>16 岁的需求。MELD-Na 并未显示优于 MELD 的优势。MELD>8.5 和 UKELD>47 预测 LT>16 岁的敏感性为 84%和 79%,特异性为 73%和 73%。PELD 的性能与 MELD 相似,但优于 UKELD。MayoPSC 显示出预测 LT>16 岁的准确性(AUROC 0.859),评分>0.87 预测 LT>16 岁的敏感性为 85%,特异性为 82%。在时间点 12 岁时,MELD 和 MayoPSC 预测 LT>16 岁。12 至 16 岁之间 MELD、PELD 和 MayoPSC 的变化与 LT>16 岁有关。
成人 LT 分配评分可能有助于监测青少年 BA 的进展,但遗漏了相关的风险因素限制了它们在该队列中的应用。特定于 BA 的预后评分将改善青少年 BA 的管理。